IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis-Reference-Cited by-同舟云学术

IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis

Published:2011-06 Issue:6 Volume:19 Page:711-718
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

Chen L.,Li D.Q.,Zhong J.,Wu X.L.,Chen Q.,Peng H.,Liu S.Q.

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology

Reference34 articles.

1. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis;Honorati;Osteoarthritis Cartilage,2002

2. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta;Benderdour;J Rheumatol,2002

3. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts;Honorati;Osteoarthritis Cartilage,2006

4. Synergism between tumor necrosis factor alpha and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes;Goldberg;Mol Immunol,2009

5. In-vitro-induced Th17 cells fail to induce inflammation in vivo and show an impaired migration into inflamed sites;Janke;Eur J Immunol,2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy;Advanced Therapeutics;2024-07-05

2. SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling;Bioscience, Biotechnology, and Biochemistry;2023-11-29

3. Inhibition of tumor immune escape by blocking PD-1/PD-L1 engagement with dual-targeting molecularly imprinted polymer layer;Cancer Nanotechnology;2023-05-11

4. Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects;Current Drug Metabolism;2023-05

5. The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors;Biomedicines;2023-04-30